IDH1 and central nervous system cancer: Unlike gliomas where IDH1 R132H mutation is predominant and can be diagnosed by immunohistochemistry,33 the distribution of IDH1 mutations is more heterogeneous in chondrosarcoma with R132C being the most frequent followed by R132G and R132L.